FGFR1 and lung adenocarcinoma: Mutations that could be genuine but would require further investigation in a larger patient cohort are AKT1, FGFR1 and ERBB2, each occurring in 1/8 of the clinical samples and are reported as low frequency occurring mutations in lung adenocarcinoma by the COSMIC database (Figure 1, Table 3).